This video is about Orion.
Orion is an innovative European R&D-based pharmaceuticals and diagnostics company that offers high-value pharmaceutical contract manufacturing services for global markets. Our current contract manufacturing portfolio includes proprietary and generic products for human and animal health in various dosage forms. Our facilities comply with EMA, FDA, JP and ANVISA quality standards.
Acknowledged quality of operations, solid project management practices, excellent customer service, and high service level form the basis of our contract manufacturing offering. The strong financial position of our company contributes to us being a reliable and capable contract manufacturing partner.
Pharmaceutical contract manufacturing and packaging of various dosage forms
Orion has fourpharmaceutical plants, all located in Finland. We offer the following dosage forms for pharmaceutical contract manufacturing:
- Hormonalsemi-solids and solutions
- Small volume parenterals (vials, ampoules)
- Solid oral dosage forms (tablets, capsules)
- Cytostatics (tablets, capsules)
- Liquids (oral and nasal liquids, nasal sprays)
- Semi-solids (creams, gels and ointments)
Hormonal semi-solids and solutions specialists
Orion has more than 20 years’ experience with developing and manufacturing hormonal gels for Orion and our customers.
Orion has vast experience with:
- Potent APIs and controlled substances
- Handling of flammable liquids
- Finding solutions for formulation and analytical challenges
- Various packaging formats
We supply to all global markets and comply with requirements from authorities in the United States, Europe, Japan, Latin America, Middle East.
Fluent and efficient technology transfer
Orion has well-established processes and strong expertise to carry out technology transfer projects efficiently, and according to customer requirements. When bringing new products into our production environment, we employ solid project management tools and practices throughout the organisation. Close co-operation with our partners is a key factor in successful technology transfers.
Continuous support for pharmaceutical product lifecycles
Orion is fully committed to providing support for the supply chain throughout the product’s lifecycle. This includes product maintenance, process development, as well as troubleshooting. Our comprehensive array of manufacturing equipment of various sizes further contributes to scale-up projects when those are needed.
Key account managers establish a personal relationship with the customer and ensure fluent and efficient co-operation. Our key account managers work in close collaboration with all the Orion line functions to meet our customers’ expectations.
Supporting services for our contract manufacturing customers
Orion supplies more than 300 different products (over 4,000SKUs) to at least 100 countries globally. The constant development of our own product portfolio drives our technical and analytical capabilities to meet the highest standards. We are able to assist our customers with:
- Supporting regulatory documentation
- Logistics arrangements
- Analytical and QP release services
- Artwork creation
Fermion, a subsidiary fully owned by Orion, is able to assist with contract research and manufacturing (CRAMS) of APIs
Orion is an innovative European R&D-based pharmaceuticals and diagnostics company with an emphasis on developing medicinal treatments and diagnostic tests for global markets.
Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients, and diagnostic tests. Orion currently employs 3,500 people, and has sales offices around Europe. Fermion is a subsidiary fully owned by Orion, which concentrates on research and manufacturing of APIs.
Orion has three modern pharmaceutical plants all located in Finland. We manufacture tablets, capsules, small volume parenterals, dry powder inhalers, creams, gels, ointments, liquids and suppositories for global markets.
Orion Pharma Animal Health and Vetoquinol have announced their collaboration regarding the distribution of Orion's sedatives product family alpha-2 agonists and antagonist Dexdomitor, Domitor and Domosedan and Antisedan.
Orion has finalised construction of its new manufacturing facility of hormonal gels and solutions. The demanding project was carried out exactly to the planned schedule, fulfilling all the set criteria for the quality of the new premises and processes.
Orion continues to develop its capabilities and capacity for manufacturing of hormonal gels and solutions for contract manufacturing customers. A large new manufacturing unit has been qualified earlier this year, providing a new option to increase batch sizes.
Orion Contract Manufacturing Sponsors Pharma Outsourcing and Procurement and GPCM Summits, June 2013
The Pharma Outsourcing and Procurement Summit, 5 - 6 June in Berlin, addresses the growing pharmaceutical outsourcing requirements in contract manufacturing, bulk, fill finish, drug delivery and API sourcing.